WASHINGTON (WGHP/WETM) — U.S. government-run vaccine sites are expected to stop offering the Johnson & Johnson coronavirus vaccine after multiple people developed blood clots, according to the New York Times.
The announcement is expected Tuesday after six people in the U.S. developed blood clots within two weeks of getting the vaccine. The Centers for Disease Control and the Food and Drug Administration is working to determine if there is a link between the vaccine and the blood clots.
The Times reported that one woman died from a possibly vaccine-related clot. Another is in critical condition.
All six of the patients were women between ages 18 and 48.
The decision to halt use of the vaccine comes after the U.S. had already used the Johnson & Johnson vaccine on nearly 7 million people, according to the New York Times.
The government is only recommending that states halt usage of the vaccine but is not requiring them to stop.
The FDA is planning to hold a news conference at 10 a.m. You can watch it here.
Local reaction; supply in the Twin Tiers
With J&J vaccines being paused, vaccine appointments are being canceled.
Angela Murray, Senior Director of Quality Management at Arnot Health, said they will wait to see what the FDA and CDC recommend then follow suit.
Murray said there is enough supply of Pfizer and Moderna to fill these canceled appointments.
“I think the supply is a bit over the demand at this point in time which is good. We have enough supply,” said Murray. “We just need to continue to educate and reinforce the need for vaccinating the population. Fortunately, we have COVID-19 vaccinations for Pfizer and Moderna and they’re available and incredibly effective alternatives to the product.”
On Apr. 17, Arnot will administer its 30,000th dose of the coronavirus vaccine.